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ABSTRACT AND KEY WORDS 
A STUDY ON THE EFFECT OF CARBONDIOXIDE AS 
PNEUMOPERITONEUM ON LIVER FUNCTIONS IN 
LAPROSCOPIC CHOLECYSTECTOMY 
AIM OF THE STUDY 
1. To study the incidence of alterations in liver function 
following laparoscopic  cholecystectomy in the Indian 
population 
2.  To study the significance of these alterations in patients and 
the safety of the     procedure 
MATERIALS AND METHODS 
This is a prospective study conducted in the department of 
General surgery, Stanley medical college, Chennai, from July 2014 to 
June 2015. 
This  chapter  presents  an  overview of    the    study  design  of  LC 
performed under variable  intraperitoneal pressure (12-14mmHg) in 
patients with cholecystectomy. 
 
SOURCE OF DATA: 
The patients admitted in our hospital wards with symptomatic 
cholelithiasis from July 2014 to June 2015 will be taken up for the 
study. 
METHOD OF COLLECTION OF DATA 
The study will be conducted on 50 patients undergoing LC under 
variable intraperitoneal pressure (12-14mmHg) at Stanley medical 
college,  chennai.  The  study  will  be  designed  to  evaluate  the  
complications of LC especially the changes in liver enzymes. 
All patients undergoing laparoscopic cholecystectomy will be 
invited to participate in the study and written informed consent will be 
taken. All patients will undergo a standard clinical and laboratory 
evaluation that includes briefly information about age, sex, address and 
routine investigation including ultra sound abdomen, which are done pre 
operatively. 
Pre-operative investigations include liver function tests (SGOT, 
SGPT, alkaline phosphatase, gamma glutamyl transferase, bilirubin 
(direct), and bilirubin(total)). 
The subject satisfying inclusion and exclusion criteria will be  
enrolled in the study.  
The liver function tests will be further done 24 hrs later and in 
some patients liver function test will be repeated to monitor liver 
function. Adverse events will be noted in all the patients. Finally the 
duration of hospital stay will be  noted. The patients who develops intra-
abdominal complications will be excluded from the study. 
CONCLUSION: 
This prospective observational type of study was conducted in 
department of General Surgery, Stanley Medical College and Hospital, 
Chennai, from 1 July 2014 to 30 June 2015.  
It can be concluded from the findings of the study that usage of 
co2 as pneumoperitoneum in laproscopic cholecystectomy has no 
significant effect on post operative liver enzymes. 
It can be concluded that variation in insuffulation pressure has no 
effect on enzyme rise significantly. 
It  can  be  observed  that  duration  of  surgery  with  co2  
pneumoperitoneum has no effect on postoperative LFT level. 
Thus co2 in safe pneumoperitoneum can be safely used in 
laproscopic surgeries. 
Key words: Laproscopic cholecystectomy, Co2 pneumoperitoneum, 
liver function test.     
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1.  INTRODUCTION 
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1.1  OBJECTIVES : 
 
AIM OF THE STUDY 
 
1. To study the incidence of alterations in liver function  
following laparoscopic cholecystectomy in the Indian 
population 
 
2. To study the significance of these alterations in patients and 
the safety of the procedure 
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2.   REVIEW OF LITERATURE 
In this modern era Laparoscopic surgery has evoked marked 
changes in approach to surgical diseases. The “Minimally invasive sur-
gery “(MIS) , now turned into “Minimal Access Surgery” (MAS) has 
prompted us to scrutinize nearly all operations for possible conversion 
to Laparoscopic technique. 
HISTORICAL ASPECTS 
In the history of surgery few procedures have so rapidly changed 
the surgeon’s way of thinking and acting as has Laparoscopic cholecys-
tectomy . It has been the true detonator of the laparoscopic revolution in 
digestive surgery. 
First Laparoscopic cholecystectomy was done by Mahein 1985. 
Moureta general surgeon performed a Laparoscopic cholecystectomy 
and few months later showed video tape of his technique in Paris 1987. 
In 1988 in Paris, Dubois and Co-workers – tried the laparoscopic 
method. During the same year, technique of internal lithotripsy for re-
moving gallstones with a laparoscopic access was developed. 
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For the first time in the United States, a videotape of laparoscopic 
cholecystectomy using intra corporeal lithotripsy technique Endoscopic 
Surgeons in Louisville, Kentucky in April 1989. 
           As early as 1992, laparoscopic cholecystectomy had become the 
procedure of choice to remove gallbladder with calculi for two main 
reasons, 
1. Constant improvement of results. 
2. Simplification of technique. 
The explosive success of laparoscopic cholecystectomy initiated 
revolution within us. At present nearly all abdominal surgeries can be 
performed laparoscopically. 
In our hospital we are doing the following laparoscopic procedures. 
1. Laparoscopic Appendicectomy 
2. Laparoscopic Cholecystectomy 
3. Diagnostic Laparoscopy 
4. Laparoscopic Ovariectomy 
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2.1  OVERVIEW OF SURGICAL ANATOMY 
 
Gallbladder  is  a  pear  shaped  organ  of  size  7.5  –  12  cm ,  with  a  
normal capacity of about 5 ml. It is located in the gallbladder fossa of 
inferior surface of right lobe of liver and covered by layer of perito-
neum. It is anatomically divided into 
 Fundus 
 Body 
 Neck (or) infundibulum through which bile drains into cystic 
duct which joins the common bile duct. Cystic artery, a branch of Right 
hepatic artery is usually given off behind the common hepatic duct sup-
plies  the  gall  bladder.  There  are  various  anomalies  of  GB,  cystic  duct  
and cystic artery course that must be recognized to avoid inadverdent 
injury during Laparoscopic cholecystectomy. Anatomy of calots triangle 
is very important either during open or Laparoscopic cholecystectomy. 
This is bounded above by the cystic artery, below by the cystic duct and 
medially by the common hepatic duct. 
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2.2  PHYSIOLOGY 
Gallstones are the most common biliary pathology. More than 
85% of patients are asymptomatic who needs expectant line of man-
agement. 
They are classified into 
1. Cholesterol stones – Most common 
2. Pigment stones which again divided into 
a) Brown pigment stones. 
b) Black pigment stones 
FACTORS IN GALLSTONE FORMATION 
a. Supersaturated bile – Most important. 
b. Impaired gall bladder function 
c. Cholesterol nucleating factors 
d. Absorption and enterohepatic circulation of bile 
      acids. 
2.3.  PATHOLOGY 
Lipids and fat soluable vitamins A,D,E,K absorption helped by 
bile.Cholesterol as well ws bilirubin excretion takes place with help of 
bile.Lipid dissolves in bile salt and get easily absorbed .  Phospholipids 
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are synthesized in the liver in conjucation with bile salt. Cholesterol is 
not soluable in water and bile and is highly non polar.The normal vol-
ume of bile secreted by the liver is 50 to 100ml/day. 
Solubility of bile salt,cheodeoxycholic acid,cholic acid is lost 
leading to gall stone formation. The primary event is formation of  
“biliary sludge”.Composition is, calcium bilirubinate granules, choles-
terol crystals and a mucin. Contributing factors are prolonged fasting 
states or total parenteral nutrition. 
CHOLESTEROL GALLSTONES : 
The multifactorial step is 
  supersaturation 
  nucleation 
  growth 
Failure of motor function leads to gallstone formation. Choles-
terol is maintained in soluable form by micelles.combination of , a bile 
salt – phospholipid – cholesterol complex and cholesterol – phosphol-
ipid vesicles. Cholesterol solubility depends on the relative concentra-
tion of cholesterol, bile salts and phospholipid. 
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Cholesterol supersaturation is present in many normal humans 
without gallstones. Thus, cholesterol supersaturation results in metasta-
ble state in which cholesterol precipitation may or may not take place 
and additional factors in bile must be present to either enhance or inhibit 
nucleation of cholesterol leading to next stage in gallstone formation. 
Nucleation refers to the process in which solid cholesterol mono-
hydrate crystals form and conglomerate. Vessicles get transferred to 
miscelles with the help of phosphplipid and cholesterol. Efficient trans-
fer of phopholipid occur than cholesterol. As aresult enrichement of 
cholesterol with remaining vesicles occurs.Cholesterol rich vesicles get 
converted to large monohydrate.Accelerating factors include immu-
noglobulin,mucinand glycoprotein. 
Clinical  symptom  occur  as  a  result  of  biliary  tree  obstruction  or  
injury of gall bladder. Growth of stones may occur in two ways. 
 Insoluble precipitate deposition at the bile – stone interface. 
 Leading to large conglomerate. 
Decrease in motility of gallbladder leads to stone formation. 
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Additive factor includes  gallbladder stasis, as starvation, parenteral nu-
trition, after vagotomy and in patients with tumours producing soma-
tostatin or in those receiving somatostatin therapy. 
PIGMENT GALLSTONES 
Anions,bilirubin,palmitate,phosphates get precipitated with cal-
cium leading to stone formation. Furthermore,  bilirubinate, and  palmi-
tate also forms major components of pigment gallstones. 
Pigment stones are classified into brown or black stones. Cause 
for black pigment stones are hemolytic anaemia or cirrhosis. In hemo-
lytic anaemia total bilirubin  and concentration of indirect bilirubin in-
creases. 
Brown pigment stones are seen most commonly in asian popula-
tion.Constitution is cholesterol and calcium palmitate.Contributing fac-
tors include disorders of biliary motility and infection. 
2.4.COMPLICATIONS OF GALLSTONES 
 
a)     In the Gall Bladder 
1. Chronic Cholecystitis 
2. Acute Cholecystitis 
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 3. Gangrene 
4. Perforation 
5. Empyema 
6. Mucocele 
7. Carcinoma 
b) In the Bile Ducts 
1.Obstructive Jaundice 
2.Cholangitis 
3.Acute Pancreatitis 
c) In the Intestine 
1.Acute intestinal Obstruction 
(Gallstone ileus) 
Silent stones are incidentally found stone during examination for 
other pathology or in routine check up, which do not produce symptoms. 
Proplylactic cholecystectomy is not indicated in all these patients except 
in the following high risk groups. 
 Diabetic patients 
 Patients on immunosuppressive therapy 
 Candidates for renal transplant 
 Large gall stone more than 2 cm 
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 Multiple small stones 
 Patients living in high risk areas where there is increased incidence of 
GB carcinoma. 
 Porcelain GB, Cholesterosis GB 
 Patient undergoing for abdominal surgery with incidental finding  of 
gall stones, if general condition of the patient permits – incidental 
cholecystectomy may be done. 
In our study the following groups of patients were taken. 
 Cholelithiasis 
 Chronic calculous cholecystitis 
 Patients with biliary colic 
GB: Assess 
 Size of GB 
 Walls of GB 
 Intraluminal Calculi 
CBD : Any calculi and diameter 
Liver : Any solid (or) cystic lesions 
Intrahepatic biliary radicle dilatation 
Pancreas : Any mass in the pancreas 
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Diameter of pancreatic duct 
2.5. INVESTIGATIONS 
1. Complete hemogram – Hb%, TC, DC, ESR 
2. Urine for routine examination 
3. Blood for sugar, urea , creatinine and electrolytes 
4. Bleeding time, clothing time and PTT 
5. Liver function test 
i. Sr. Bilirubin – Total / Direct 
ii. SGOT 
iii. SGPT 
iv. Alkaline Phosphatase 
v. Proteins 
6. Chest X-ray PA view 
7. ECG 
8. USG Abdomen 
      Reliable investigation for evaluation of biliary tract diseases. 
2.6.  LAPAROSCOPIC INSTRUMENTS 
The surgeons knowledge of instrumentation and ability to  
“trouble shoot” certainly help to allay anxiety and contribute to optimal 
patient care. 
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OPERATING ROOM SETUP 
The operating room setup includes equipment which properly  
positions the patient. Operative laparoscopic and video equipment and 
well coordinated assistant and nursing team are all required. 
Anasthesiologist should be well versed with the potential  
problems and complications of laparoscopy. 
ESSENTIAL EQUIPMENTS 
a). Optic Equipments 
 Laparoscope 5mm, 10mm – 100, 300 
 Computed chip video camera 
 Light source 
 Video monitors and video recorder 
b) Abdomen Access Equipments 
 Veress needle 
 Hasson cannula 
 Gas cylinder (C02) 
 Trocar and cannulas 
 Insufflators 
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c). Laparoscopic Instruments 
 Atraumatic grasping forceps 
 Bipolar coagulation forceps 
 Dissecting forceps – Maryland 
 Scissors 
 Clip applicators 
 Staplers 
 Endo pouches (or) Sacs 
 Sutures and needles 
 Needle holder  
 Suction and irrigation system 
LIGHT SOURCE 
High intensity light source (Xenon) is necessary for adequate il-
lumination of peritoneal cavity. The light source is connected to the 
laparoscope by either fibre optic cable (or) fluid filled cable. The fibre 
optic cables consist of an inner core of glass that has a high refractive 
index which absorbs much of the light input. 
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VIDEO CAMERA 
Eye piece of laproscope is attached to video camera and has focus 
mechanism and zooming power. 
The resolving power must  be 400 lines of resolution per inch and 
has charge coupled device. 
VIDEO MONITOR 
The monitor resolution capability  and video camera should match 
with each other and such monitor is selected. Three chip cameras re-
quire expensive monitors with 700 lines of resolution. 
LAPAROSCOPES 
Commonly used laparoscopes are rigid instruments that employ 
the Hopkins rod lens system of optics. It comes in sizes ranging between 
between 3mm to 10mm in diameter and variety of viewing angles. The  
0 degree or end/ forward viewing is easy to use and results in least 
amount of image distortion. Angled scopes (30o, 45o) provide greater 
versatality by following the operator to looks around corners and solid 
organs but needs experience. Recently, flexible scopes have been devel-
oped. 
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INSUFFALATORS 
Insuffalators used to create working space within the abdominal 
cavity by delivering C02 via an automatic high flow pressure – regulator 
system. C02 is currently the agent of choice because of low toxicity, low 
risk of gas embolism, rapid reabsorption, low cost and ease of use. Ideal 
insuffalator should be able to deliver 8 to 10L/min with a minimum ac-
ceptable flow rate of 6L/min. It regulates flow rate, monitors intra ab-
dominal pressure and stops delivering C02 whenever the pressure ex-
ceeds predetermined level of 12 to 15mm Hg. 
PUNCTURE INSTRUMENTS 
To gain access to the peritoneal cavity 2 types of instruments 
used, 
1.  Veress needle 
2. Laparoscopic trocar – sheath assemblies Veress needle achieve 
pneumoperitoneum in a “Closed” fashion. 
It has outer sharp cutting needle and inner blunt spring loaded  
obturator. Once cutting needle enter peritoneal cavity blunt stylet 
springs forward thereby reducing injury. 
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Hasson cannula is used to create pneumoperitoneum in a 
“opened” fashion. By using this we may avoid inadverdent injury to the 
bowel and vessels which may occur occasionally. 
The basic laparoscopic port consists of an outer hollow sheath  
or cannula that has a valve to prevent C02 escape, side port for insuffa-
lation of gas and a portal for instrument access. The commonly used  
trocars are 5 mm and 10 mm in diameter. 
SURGICAL INSTRUMENTS 
They are modification of standard surgical instruments, shaft of 
these may be insulated with non-conductive material and the working 
tips are metal to allow use with electrocautery. 
i. Dissecting forceps 
Equipped with atraumatic tips that can be used to dissect and 
spread tissues bluntly. Forceps with gentle curve for dissecting around 
cornersalso available. 
ii. Grasping forceps 
It comes with either atraumatic or toothed jaws and has ratchet for 
locking onto the tissues being grasped. 
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iii. Scissors 
Scissors with Metzenbaum – type configuration of tip useful for 
procedures like adhesiolysis. 
iv. Clip appliers 
They are the primary modality for ligating blood vessels and tu-
bular structures. The clips are made of titanium and range from 7mm to 
1mm. 
v. The Push rod and suture loop 
They are inserted via a hollow reducing sleeve. The suture then 
looped around the structure and the knot slide down and closed. 
2.7. SURGICAL PROCEDURE 
The two modalities used for coagulation and the hemostasis are 
the laser and electrocautery – monopolar or bipolar. The entire tip of the 
instrument must be well visualized to avoid contact with other structures 
there by avoiding thermal injuries 
The laparoscopic cholecystectomy offers many advantages that 
include a markedly reduction in hospital stay and decreased cost. 
 Patient preparation, induction of anesthesia, and sterile draping are  
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performed as for an open cholecystectomy. Although use of a urinary 
catheter depends on the clinical setting, an orogastric tube is standard to 
decompress the stomach and help with exposure of the upper abdomen. 
Access to the peritoneal cavity and creation of pneumoperitoneum can 
be performed by the open or closed technique according to the expertise 
and discretion of the surgeon. The open technique involves making a 
small incision at the umbilicus,   cutting   down through the fascia of the 
abdominal    wall, incising the peritoneum directly, and inserting a blunt 
trocar, known as a Hasson cannula.  
   Alternatively  in the closed technique, an incision is made and a 
needle inserted into the peritoneal cavity to insufflate the abdomen prior 
to the placement of  any trocars.  Following the establishment of  a  CO2 
pneumoperitoneum, a brief exploration is performed and additional  
5-mm ports are placed in the right anterior axillary line, right  
midclavicular line, and subxiphoid location ). The lateral port at the  
anterior axillary line is used to elevate the fundus of the gallbladder  
toward the right shoulder. This retraction provides exposure to the  
infundibulum and porta hepatis. The midclavicular trocar is used to 
grasp thegallbladder infundibulum, retracting it inferolaterally to open 
the triangle of Calot. By distracting Hartmann’s pouch laterally, the  
cystic duct no longer lies almost parallel to the common hepatic duct. 
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The dissection is then carried along the infundibulum on the anterior and 
posterior surfaces to expose the base of the gallbladder. This dissection 
will eventually clear all fibrofatty tissue from the triangle of Calot.  
Inferolateral traction of the infundibulum then allows documentation of 
two structures entering the gallbladder, the cystic duct and cystic artery. 
A useful landmark for the cystic artery is the overlying lymph node, 
known as Calot’s node. The view of the liver bed through the space  
between cystic duct and cystic artery and above the cystic artery is 
known as the critical view of safety, and minimizes the risk of inadver-
tent iatrogenic bile duct injury . With sufficient dissection, clips are 
placed on the cystic artery and cystic duct. If a cholangiography is  
performed, the cystic duct is only clipped adjacent to the gallbladder and 
the cystic duct incised, although not transected. A cholangiographic 
catheter is then fed through the incised duct and fluoroscopic images  
obtained with injection of contrast into the cystic duct and biliary tree. 
On obtaining a normal cholangiogram or when cholangiography is not 
performed,  the  cystic  duct  is  doubly  clipped  on  the  common duct  side  
and transected. The previously clipped artery is also transected and the 
gallbladder dissected off the liver bed using electrocautery. Because the 
venous drainage of the gallbladder is directly into the liver bed through 
venules, excellent hemostasis must be achieved during this dissection. 
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The cystic  duct  and cystic  artery clips are inspected just  prior  to 
completion of the dissection of the fundic attachments, because the  
superior traction of the fundus has provided exposure to the porta and 
triangle of Calot. The gallbladder is then brought out of the abdominal 
cavity through the umbilical port. In the setting of acute cholecystitis, or 
if during dissection the gallbladder was entered, a plastic bag should be 
used for retrieval. 
THE PHYSIOLOGIC EFFECTS OF PNEUMOPERITONEUM 
The pneumoperitoneum has many effects that are only partially 
known. There are effects resulting from the pressure within the abdomen 
and effects resulting from the composition of the gas used, generally 
carbon dioxide. 
The pressure within the abdomen from pneumoperitoneum  
decreases venous return by collapsing the intra-abdominal veins,  
especially in volume-depleted patients. This decrease in venous return 
may lead to decreased cardiac output. To compensate, there is an  
elevation in the heart rate, which increases myocardial oxygen demand. 
High-risk cardiopulmonary patients cannot always meet the demand and 
may not tolerate a laparoscopic procedure. In volume-expanded healthy 
patients with full intra-abdominal capacitance vessels (veins), the  
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increased intra-abdominal pressure actually may serve as a pump that 
increases right atrial filling pressure. 
Through a different mechanism associated with catecholamine re-
lease triggered by CO2 pneumoperitoneum, heart rate rises along with 
systemic vascular resistance. This may lead to hypertension and impair 
visceral blood flow. It is not uncommon after the induction of  
pneumoperitoneum for the heart rate to rise along with the mean arterial 
pressure.   However,  in  elderly,  compromised  patient,  the  strain  on  the  
heart can lead to hypotension, end-organ hypoperfusion, and  
ST-segment changes. 
To minimize the cardiovascular effects of pneumoperitoneum, it 
is important that patients have adequate preoperative hydration. By  
insufflating the abdomen slowly, the vagal response to peritoneal 
stretching may be diminished and vagally mediated bradycardia 
avoided. Additionally, if cardiovascular effects are noted during  
insufflation or during the maintenance of pneumoperitoneum, the  
insufflation pressures should be lowered from the usual 15 to 12 mmHg, 
or pneumoperitoneum should be evacuated while the anesthesiologist 
sorts out the cardiovascular changes. Taking patients out of the steep  
  23
reverse Trendelenburg position can help to increase venous return. 
Sometimes these effects can last for hours after desufflation. 
The elevated intra-abdominal pressures restrict movement of the 
diaphragm, which reduces diaphragmatic excursion. This is represented 
as a decrease in functional residual capacity and pulmonary compliance 
and an increase in inspiratory pressure. Overall, there is no significant 
change in the physiologic dead space or shunt in patients without  
cardiovascular compromise. After the induction of pneumoperitoneum, 
peak  airway  and  plateau  airway  pressures  increased  by  50% and  81%,  
respectively. Bronchopulmonary compliance decreased by 47% during 
the period of increased intra-abdominal pressure. After desufflation, 
peak and plateau pressures remained elevated by 36% and 27%,  
respectively,  for  2AND6  hours.  Compliance  remained  at  86%  of  the  
preinsufflation value. 
Urine output often is diminished during laparoscopic procedures 
and usually is the result of diminished renal blood flow owing to the 
cardiovascular effects of pneumoperitoneum and direct pressure on the 
renal veins. In addition to direct effects, elevated intra-abdominal  
pressure results in release of antidiuretic hormone (ADH) by the  
pituitary, resulting in oliguria that may last 60 minutes after the  
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pneumoperitoneum is released. Aggressive fluid hydration during 
pneumoperitoneum increases urine output. Positional changes can affect 
the collection of urine in the Foley catheter and must be taken into  
consideration if anuria is noted. 
CARBON DIOXIDE RELATED EFFECTS 
HYPERCAPNIA 
Hypercapnia and acidosis are seen with pneumoperitoneum and 
are likely due to the absorption of carbon dioxide from the peritoneal 
cavity. In the ventilated patient, increasing respiratory rate or vital  
capacity must compensate for these changes. At extremes, increases in 
tidal volume may risk barotraumas, and increases in respiratory rates 
diminish time for gas mixing, increasing dead-space ventilation. A first 
steady state in PaCO2 is reached around 30 minutes after introduction of 
the pneumoperitoneum. After this period, increases in PaCO2 suggest 
that existing body buffers (>90% exist in bone) have been exhausted. 
Sudden increases may be related to port slippage and extraperitoneal  
or subcutaneous diffusion of carbon dioxide. This will resolve  
spontaneously once the port is repositioned. 
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Hypercapnia and acidosis that are difficult to control may follow, 
especially in elderly patients, those undergoing long operations, and  
patients with pulmonary insufficiency. Our response to this is to  
desufflate the abdomen for 10 to15 minutes. If reinsufflation results in 
recurrent hypercapnia, then we change insufflation gases  or convert to 
an open operation. Acidosis can persist for hours after desufflation. 
Other complications of pneumoperitoneum that are less frequent but 
may be life threatening include CO2 embolism and capnothorax. 
CARBON DIOXIDE EMBOLUS 
The incidence of clinically significant CO2 embolism is very low, 
although recent reports using more sensitive tests suggest that tiny  
bubbles of gas are present commonly in the right side of the heart during 
laparoscopic procedures. Clinically important CO2 embolism may be 
noted by unexplained hypotension and hypoxia during the operation. 
There is a characteristic millwheel murmur that can be detected with 
auscultation  of  the  chest.  This  is  produced  by  contraction  of  the  right  
ventricle against the blood-gas interface. Usually the anesthesiologist 
notes an exponential decrease in the end-tidal CO2, which is consistent 
with complete right ventricular outflow obstruction. The mainstays of 
treatment are immediate evacuation of the pneumoperitoneum and 
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placement of the patient in the left lateral decubitus, head down (Durant) 
position.  This allows the CO2 bubble to "float" to the apex of the right 
ventricle, where it is less likely to cause right ventricular outflow  
tract obstruction. It is important to administer 100% oxygen and  
hyperventilate the patient during this period. Additionally, aspiration of 
gas through a central venous line may be performed. 
CAPNOTHORAX/PNEUMOTHORAX 
Capnothorax can be caused by carbon dioxide escaping into the 
chest through a defect in the diaphragm or tracking through fascial 
planes during dissection of  the esophageal  hiatus.  It  also can be due to 
opening of pleuroperitoneal ducts most commonly seen on the right 
side. Pleural tears during fundoplication can lead to pneumothorax, and 
additionally, the usual causes of pneumothorax, such as ruptured bullae, 
may be the etiology. The effects of carbon dioxide gas in the chest  
usually are noted as decreased O2 saturation (a result of shunting  
induced by lung collapse), increased airway pressure, decreased  
pulmonary compliance, and increases in carbon dioxide and end-tidal 
CO2. The treatment is to desufflate the abdomen and stop carbon dioxide 
administration, correct the hypoxemia by adjusting the ventilator, apply 
positive end-expiratory pressure (PEEP), if possible, and decrease the 
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intra-abdominal pressure as much as possible. The recommendation is to 
avoid thoracentesis because this usually resolves with anesthetic  
management. We generally evacuate the capnothorax directly at the end 
of the procedure with a red rubber catheter placed across the diaphragm 
(through  the  pleural  defect)  and  brought  out  a  trocar  site.  The  external  
end of the catheter is placed under water as the lung is inflated and then 
removed from the water when the bubbles stop. We do not obtain chest 
radiographs in the recovery room after these maneuvers if there is no 
evidence of hypoxia on 2 L/min of O2 flow. Patients should be  
maintained on supplemental oxygen to help facilitate absorption of the 
carbon dioxide from the pleural space. 
Although, various studies on laparoscopic cholecystectomy  
are available, the frequency and duration of postoperative  
pneumoperitoneum are not well established. Moreover, the observation 
of hemodynamic and metabolic impairment related to CO2 
 pneumoperitoneum and postoperative mesenteric ischemia reports  
following laparoscopic procedures have raised concern about local and 
systemic effects of increased intra abdominal pressure during  
laparoscopic procedures. This study aims to investigate the effect of 
carbon dioxide used as pneumoperitoneum over liver functions in lap 
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cholecystectomy under pressure [12-14mmHg] at Stanley medical  
college, Chennai 
AIMS AND OBJECTIVES OF THE STUDY: 
1. To study the incidence of alterations in liver function fol-
lowing laparoscopic cholecystectomy in the Indian population. 
2. To study the significance of these alterations in patients and 
the safety of the procedure. 
3. MATERIALS AND METHODS 
This is a prospective study conducted in the department of  
General Surgery, Stanley Medical College, Chennai, from July 2014 to  
June 2015. 
This  chapter  presents  an  overview  of   the   study  design  of  LC   
performed under constant intraperitoneal pressure (14mmHg) in patients 
with cholecystectomy. 
SOURCE OF DATA: 
The patients admitted in our hospital wards with symptomatic 
cholelithiasis from June 2013 to July2014 will be taken up for the study. 
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METHOD OF COLLECTION OF DATA (including  
sampling procedure, if any 
The study will be conducted on 50 patients undergoing LC under 
variable intraperitoneal pressure (12-14mmHg) at Stanley medical  
college, Chennai. The study will be designed to evaluate the  
complications of LC especially the changes in liver enzymes. 
All patients undergoing laparoscopic cholecystectomy will be  
invited to participate in the study and written informed consent will be 
taken. All patients will undergo a standard clinical and laboratory  
evaluation that includes briefly information about age, sex, address and 
routine investigation including ultra sound abdomen, which are done pre 
operatively. 
Pre-operative investigations include liver function tests (SGOT, 
SGPT, alkaline phosphatase, gamma glutamyl transferase, bilirubin  
(direct), and bilirubin(total)). 
The subject satisfying inclusion and exclusion criteria will be   
enrolled in the study. 
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The liver function tests will be further done 24 hrs later and in 
some patients liver function test will be repeated to monitor liver  
function. Adverse events will be noted in all the patients. Finally the  
duration of hospital stay will be  noted. The patients who develops  
intra-abdominal complications will be excluded from the study. 
3.1  Type of study :Prospective and Observational Study 
3.2 Study approval :Prior to commencement of this study - Thesis & 
Ethical Committee of Stanley Medical College and Hospital, 
Chennai had approved the thesis protocol. 
3.3  Place of study : Stanley Medical College and Hospital 
3.4  Period of study :Duration starting from 01 July 2014 to 30 June 
2015 
3.5  Sample size :50 cases with comparative control group of 50 cases 
3.6  Selection of patients: 
a)  Sampling method- Purposive. 
b)  Inclusion criteria- Patients with symptomatic or asymptomatic 
cholelithiasis or choledocholithiasis, age 20 to 80 yrs. 
c)  Exclusion criteria - - Any patient with pre-operative abnormality 
in liver enzymes. 
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x Suspected chronic liver diseases 
x Common bile duct pathology 
x Conversion to open cholecystectomy 
x Hematological Disorders 
x Intra – Operative Complication – CBD injury 
x Incomplete data 
3.7  STUDY PROCEDURE 
Method of sampling was non-random, purposive. After admission 
short history was taken and physical examination was conducted on 
each patient admitted in surgery department with features suggestive of 
extrahepatic biliary lithiasis. Baseline investigations, as routinely  
required, were done, followed by imaging studies. Patients were then 
explained about their disease process and the possible line of  
management. All the necessary information regarding the study was  
explained to the patients or their valid guardian. Informed written  
consent was taken from the patients or their guardian willing to  
participate in the study. Detailed history was taken from the study group 
to establish proper diagnosis. Thorough physical examination was done 
in each case. Data collection sheets were filled in by the investigator 
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himself. All of the preoperative factors related to the patient were noted 
down in the data sheet. After proper evaluation and preparation, patients 
who required surgical management were taken up for surgery. Strict 
aseptic precautions were followed during the operation. Meticulous 
techniques were practiced as far as possible. The operation procedure 
and related preoperative factors were observed directly and recorded in 
the data collection sheet instantly. 
After completing the collection of data it was compiled in a  
systematic way. Operational definitions: 
Cholelithiasis :a condition marked by presence of calculi in the 
gallbladder. 
Choledocholithiasis :a condition marked by presence of calculi 
in the common bile duct. 
Jaundice :Those with S. bilirubin >1.2 mg/ dl were recorded as 
jaundiced. 
Diabetes :Those known as diabetic from history and those with 
RBS more than 11 mmol/ l were included as diabetic. 
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ERCP: (endoscopic retrograde cholangiopancreatography)  
is a procedure used to diagnose and treat diseases of the  
gallbladder, biliary system, pancreas, and liver. 
4. RESULTS 
This prospective and observational study was carried out to de-
termine the effect of co2 on liver function test was studied. 
Fifty patients fulfilling the inclusion criteria from Surgery  
department of  Stanley Medical College and Hospital during the period 
of 1 July 2014 to 30 June 2015. 
All cases were evaluated clinically. 
Only essential investigations necessary for diagnosis and  
preoperative assessment were carried out before operations. 
All patients underwent post op LFT in addition. 
The patients of both sexes and different ages were included in the 
study. The results obtained are as follows. 
Types of operations: were recorded during each operation. 
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Table 1 : Age and Sex Distribution of patients with cholelithiasis 
SEX Frequency Percent 
MALE 10 20.0 
FEMALE 40 80.0 
Total 50 100.0 
 
FIG 1:AGE DISTRIBUTION IN CHART 
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TABLE 2: PERCENTAGE OF SEX DISTRIBUTION 
AGE GROUP Frequency Percent 
26-35 YEARS 19 38.0 
36-45 YEARS 10 20.0 
46-60 YEARS 14 28.0 
> 60 YEARS 7 14.0 
Total 50 100.0 
 
 
The mean age of patients was 44.75 with more than half of the  
patients (38%) belonging to the 26-35 age group. The male to female 
ratio was 1 : 4. 
FIG 2:AGE WISE DISTRBUTION 
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Co2 pnuemoperitoneum  was used as variable, group 1 as 12mm 
Hg  pressure, group 2 as 13mm Hg pressure and group 3 as 15 mm  Hg 
pressure. group 2 is used as standards. preoperative T.B. doent show 
significant rise {P>0.5}. 
TABLE 3:COMPARISION FOR TOTAL BILIRUBIN PREOP 
AND POSTOP 
Descriptive Statistics 
 CO2 Pressure used Mean Std. Deviation N 
PRE_TB 
GROUP 1 1.150 .4590 16 
GROUP 2 1.171 .5977 17 
GROUP 3 1.153 .4598 17 
Total 1.158 .5002 50 
POST_TB 
GROUP 1 1.006 .3678 16 
GROUP 2 1.106 .4175 17 
GROUP 3 1.082 .3909 17 
Total 1.066 .3874 50 
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Tests of Between-Subjects Effects 
Measure:   Total bilirubin 
Transformed Variable:   Average 
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
Intercept 123.406 1 123.406 379.974 .000 .890 
CO2 Pressure used .061 2 .031 .094 .910 .004 
Error 15.264 47 .325    
 
Effect of  Co2 pnuemoperitoneum was studied and preop and post 
of direct bilirubin doesn’t show significant rise[P is 0.2939]. 
 
  38
TABLE 4:COMPARISION BETWEEN CO2 PRESSURE AND 
TOTAL BILIRUBIN 
Descriptive Statistics 
 
CO2Pressure 
used 
Mean 
Std.  
Deviation 
N 
PRE_DB 
GROUP 1 .325 .1693 16 
GROUP 2 .347 .2939 17 
GROUP 3 .418 .2186 17 
Total .364 .2328 50 
POST_DB 
GROUP 1 .244 .1590 16 
GROUP 2 .213 .1100 17 
GROUP 3 .312 .1900 17 
Total .256 .1589 50 
 
variable co2 pneumoperitoneum pressure doesn’t have any effect 
over the rise in serum direct bilirubin levels {P is 0.267}. 
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Tests of Within-Subjects Effects 
Measure:   diff_br 
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
DB 
Sphericity Assumed .286 1 .286 12.498 .001 .210 
Greenhouse-Geisser .286 1.000 .286 12.498 .001 .210 
Huynh-Feldt .286 1.000 .286 12.498 .001 .210 
Lower-bound .286 1.000 .286 12.498 .001 .210 
DB * 
CO2PRESS
UREUSED 
Sphericity Assumed .012 2 .006 .252 .778 .011 
Greenhouse-Geisser .012 2.000 .006 .252 .778 .011 
Huynh-Feldt .012 2.000 .006 .252 .778 .011 
Lower-bound .012 2.000 .006 .252 .778 .011 
Error(DB) 
Sphericity Assumed 1.077 47 .023 
Greenhouse-Geisser 1.077 47.000 .023 
Huynh-Feldt 1.077 47.000 .023 
Lower-bound 1.077 47.000 .023 
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TABLE 5: Tests of Within-Subjects Contrasts for direct bilirubin 
Measure:   d.b. 
Source DB 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
DB Linear .286 1 .286 12.498 .001 .210 
DB * CO2  
Pressure used 
Linear 
.012 2 .006 .252 .778 .011 
Error(DB) Linear 1.077 47 .023    
 
TABLE 6: Tests of Between-Subjects Effects direct bilirubin and 
CO2 
Measure:   d.b. 
Transformed Variable:   Average 
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
Intercept 9.583 1 9.583 169.938 .000 .783 
CO2  
Pressure used 
.153 2 .077 1.360 .267 .055 
Error 2.650 47 .056    
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FIG 3:GRAPHICAL REP OF SERUM BILIRUBIN 
 
 
SGOT,SGPT and ALP dosent show any significant rise in the values 
postoperatively 
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TABLE 7: COMPARISON BETWEEN PREOP AND POST OP 
SGOT 
Descriptive Statistics 
 CO2 Pressure used Mean 
Std.  
Deviation 
N 
PRE_SGOT 
GROUP 1 30.56 16.749 16 
GROUP 2 31.94 13.530 17 
GROUP 3 34.12 17.744 17 
Total 32.24 15.831 50 
POST_SGOT 
GROUP 1 34.56 15.327 16 
GROUP 2 32.88 15.419 17 
GROUP 3 32.06 16.338 17 
Total 33.14 15.421 50 
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TABLE 8:Tests of Within-Subjects Effects for SGOT 
Measure:   sgot 
Source 
Type III 
Sum of 
Squares 
Df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
SGOT 
Sphericity 
Assumed 
23.059 1 23.059 .619 .435 .013 
Greenhouse-
Geisser 
23.059 1.000 23.059 .619 .435 .013 
Huynh-Feldt 23.059 1.000 23.059 .619 .435 .013 
Lower-bound 23.059 1.000 23.059 .619 .435 .013 
SGOT * 
CO2Pressure 
used 
Sphericity 
Assumed 
151.309 2 75.654 2.032 .142 .080 
Greenhouse-
Geisser 
151.309 2.000 75.654 2.032 .142 .080 
Huynh-Feldt 151.309 2.000 75.654 2.032 .142 .080 
Lower-bound 151.309 2.000 75.654 2.032 .142 .080 
Error(SGOT) 
Sphericity 
Assumed 
1749.941 47 37.233    
Greenhouse-
Geisser 
1749.941 47.000 37.233    
Huynh-Feldt 1749.941 47.000 37.233    
Lower-bound 1749.941 47.000 37.233    
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TABLE 9:  Tests of Within-Subjects Contrasts for SGOT 
Measure:   sgot 
Source SGOT 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
SGOT Linear 23.059 1 23.059 .619 .435 .013 
SGOT * CO2  
Pressure used 
Linear 
151.309 2 75.654 2.032 .142 .080 
Error(SGOT) Linear 1749.941 47 37.233    
 
TABLE 10:Tests of Between-Subjects Effects for sgot 
Measure:   sgot 
Transformed Variable:   Average 
Source 
Type III 
Sum of 
Squares 
Df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
Intercept 106760.043 1 106760.043 227.837 .000 .829 
CO2 Pressureused 8.544 2 4.272 .009 .991 .000 
Error 22023.346 47 468.582    
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FIG 4:estimated marginal means of SGOT 
 
 
 
 
  46
 
Table 11:Descriptive Statistics for SGPT 
 
 
CO2 Pressure 
 used 
Mean 
Std.  
Deviation 
N 
PRE_SGPT 
GROUP 1 30.31 8.670 16 
GROUP 2 27.47 10.235 17 
GROUP 3 33.59 16.447 17 
Total 30.46 12.331 50 
POST_SGPT 
GROUP 1 34.81 7.756 16 
GROUP 2 31.53 11.336 17 
GROUP 3 32.24 15.393 17 
Total 32.82 11.821 50 
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Tests of Within-Subjects Effects   Measure:   sgpt 
Source 
Type III 
Sum of 
Squares 
Df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
SGPT 
Sphericity Assumed 200.683 1 200.683 2.856 .098 .058 
Greenhouse-Geisser 200.683 1.000 200.683 2.856 .098 .058 
Huynh-Feldt 200.683 1.000 200.683 2.856 .098 .058 
Lower-bound 200.683 1.000 200.683 2.856 .098 .058 
SGPT *  
Emer_Elect 
Sphericity Assumed 120.677 1 120.677 1.717 .197 .036 
Greenhouse-Geisser 120.677 1.000 120.677 1.717 .197 .036 
Huynh-Feldt 120.677 1.000 120.677 1.717 .197 .036 
Lower-bound 120.677 1.000 120.677 1.717 .197 .036 
SGPT * CO2  
Pressureused 
Sphericity Assumed 214.385 2 107.193 1.525 .228 .062 
Greenhouse-Geisser 214.385 2.000 107.193 1.525 .228 .062 
Huynh-Feldt 214.385 2.000 107.193 1.525 .228 .062 
Lower-bound 214.385 2.000 107.193 1.525 .228 .062 
Error(SGPT) 
Sphericity Assumed 3232.735 46 70.277    
Greenhouse-Geisser 3232.735 46.000 70.277    
Huynh-Feldt 3232.735 46.000 70.277    
Lower-bound 3232.735 46.000 70.277    
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Tests of Within-Subjects Contrasts 
Measure:   sgpt 
Source SGPT 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
SGPT Linear 200.683 1 200.683 2.856 .098 .058 
SGPT * Emer_Elect Linear 120.677 1 120.677 1.717 .197 .036 
SGPT * CO2  
Pressure used 
Linear 
214.385 2 107.193 1.525 .228 .062 
Error(SGPT) Linear 3232.735 46 70.277    
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Tests of Between-Subjects Effects 
Measure:   sgpt 
Transformed Variable:   Average 
 
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
Intercept 7494.873 1 7494.873 33.213 .000 .419 
Emer_Elect 147.587 1 147.587 .654 .423 .014 
CO2 Pressure 
used 
311.557 2 155.778 .690 .507 .029 
Error 10380.523 46 225.664    
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FIG 5:estimated marginal means of SGPT 
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TABLE 12:Descriptive Statistics for ALP 
 
CO2Pressure
used 
Mean 
Std. De-
viation 
N 
PRE_ALP 
GROUP 1 48.81 32.421 16 
GROUP 2 66.24 83.140 17 
GROUP 3 48.71 34.657 17 
Total 54.70 55.145 50 
POST_ALP 
GROUP 1 56.63 40.512 16 
GROUP 2 53.82 43.411 17 
GROUP 3 50.24 23.618 17 
Total 53.50 36.150 50 
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Tests of Within-Subjects Effects 
Measure:   alp 
Source 
Type III 
Sum of 
Squares 
Df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
ALP 
Sphericity As-
sumed 
460.467 1 460.467 1.021 .318 .022 
Greenhouse-
Geisser 
460.467 1.000 460.467 1.021 .318 .022 
Huynh-Feldt 460.467 1.000 460.467 1.021 .318 .022 
Lower-bound 460.467 1.000 460.467 1.021 .318 .022 
ALP * 
EMER_ELE
CT 
Sphericity As-
sumed 
436.933 1 436.933 .969 .330 .021 
Greenhouse-
Geisser 
436.933 1.000 436.933 .969 .330 .021 
Huynh-Feldt 436.933 1.000 436.933 .969 .330 .021 
Lower-bound 436.933 1.000 436.933 .969 .330 .021 
ALP * 
CO2PRESSU
REUSED 
Sphericity As-
sumed 
2069.697 2 1034.849 2.295 .112 .091 
Greenhouse-
Geisser 
2069.697 2.000 1034.849 2.295 .112 .091 
Huynh-Feldt 2069.697 2.000 1034.849 2.295 .112 .091 
Lower-bound 2069.697 2.000 1034.849 2.295 .112 .091 
Error(ALP) 
Sphericity As-
sumed 
20740.463 46 450.880    
Greenhouse-
Geisser 
20740.463 46.000 450.880    
Huynh-Feldt 20740.463 46.000 450.880    
Lower-bound 20740.463 46.000 450.880    
  53
TABLE 13:Tests of Within-Subjects Contrasts for ALP 
Measure:   ALP 
Source ALP 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial Eta 
Squared 
ALP Linear 460.467 1 460.467 1.021 .318 .022 
ALP * Emer_Elect Linear 436.933 1 436.933 .969 .330 .021 
ALP * CO2 Pres-
sure used 
Linear 
2069.697 2 1034.849 2.295 .112 .091 
Error(ALP) Linear 20740.463 46 450.880    
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TABLE14:Tests of Between-Subjects Effects for ALP 
Measure:   ALP 
Transformed Variable:   Average 
Source 
Type III Sum 
of Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
Intercept 67740.512 1 67740.512 17.447 .000 .275 
Emer_Elect 9501.972 1 9501.972 2.447 .125 .051 
CO2 Pressure 
used 
4091.062 2 2045.531 .527 .594 .022 
Error 178596.938 46 3882.542    
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FIG 6:ESTIMATED MARGINAL MEANS OF ALP 
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5.   DISCUSSION 
This prospective, observational and comparative study was con-
ducted among 50 purposively selected patients with evidence of chole-
lithiasis  in department of General Surgery, Stanley Medical College and 
Hospital. The study was carried out with a view to determine the effect 
of co2 as pneumoperitoneum on liver functions during laproscopic 
cholecystectomy in view of determining its importance as it have no 
such role in raising the liver enzymes. Age of 50 patients ranged from 
28-77 years. Most of the patients (19,38%) were in between 25-36 
years; with mean age 30years and standard deviation 1.83 years. 20% of 
the patients were males while 80% of the patients were females. The 
male to female ratio was ~ 1 : 4.females are predominating the study. 
 
The study is based on additive ANOVA model. The effect of Co2 
on individual liver enzymes were studied. The surgery is classified 
based on emergency or elective. Based on duration of study classified as 
group 1<30 min,  group 2,30-90 min, group 3,90-135 min, group 4, 
>135 min. Preoperative T.B. shows mean value of 1.171 and standard  
deviation of 0.5977 and post op T.B. mean value of 1.106 and SD of 
0.4175. Preop D.B was mean 0.347 with SD 0.29.post op D.B. was 
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0.213 and SD of 0.11.with p value of 0.77. Pre operative SGOT with 
mean 31.94 and SD 13.53 and post operative SGOT with mean 32.88 
and SD 15.4 with p value 0.197. Preoperative ALP was mean with SD  
is 66..24 and 83.14 and post operative value 53.82 and SD 43.411 and  
p value was 0.125. 
5.2. LIMITATIONS OF THE STUDY 
As this  study  has  been  carried  out  over  a  limited  period  of  time  
with  a  limited  number  of  patients  and  there  was  lack  of  financial  and   
infrastructural support, it could not have been large enough to be of  
reasonable prescision. All the facts and figures mentioned here may 
considerably vary from those of large series covering wide range of 
time, but still then, as the cases of this study were collected from a  
tertiary level hospital in our country. 
5.3. SUMMARY 
5.4. CONCLUSION 
This prospective observational type of study was conducted in 
department of General Surgery, Stanley Medical College and Hospital, 
Chennai, from 1 July 2014 to 30 June 2015.  It can be concluded from 
the findings of the study that usage of co2 as pneumoperitoneum in  
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laproscopic cholecystectomy has no significant effect on post operative 
liver enzymes. 
It can be concluded that variation in insuffulation pressure has no 
effect on enzyme rise significantly. 
It can be observed that duration of surgery with co2 pneumoperi-
toneum has no effect on postoperative LFT level. 
Thus co2 in safe pneumoperitoneum can be safely used in  
laproscopic surgeries. 
5.5. RECOMMENDATIONS 
On  the  basis  of  the  findings  of  the  study,  the  following  recom-
mendations can be made: 
1. Co2 can be recommended in all laproscopic surgeries as  
insuffulator. 
2. Further research is necessary in large scale for guidance regarding   
management. 
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PROFORMA 
Study on the effect of carbondioxide used as pneumoperitoneum 
on liver functions in laproscopic cholecystectomy. 
Investigator: Dr. K. CHANDRASEKARAN,  PG  3rd  year  –  MS   
(General Surgery) 
Guide: Prof. Dr. RUKMANGADAN,PROF.DR.RAJENDRAN, 
Chief, Unit S5 
• NAME  :             SL. NO: 
• AGE /SEX:  
• ADDRESS WITH CONTACT NUMBER: 
• IP NO: 
• DATE OF ADMISSION: 
• DATE OF SURGERY: 
: HISTORY OF PRESENTING ILLNESS: 
PAST HISTORY: 
WHETHER A KNOWN CASE OF DM/ HYPERTENSION/ ASTHMA 
/ TB/EPILEPSY/ CARDIAC ILLNESS 
H/O SIMILAR EPISODES IN THE PAST, IF ANY: 
CLINICAL EXAMINATION: 
GENERAL EXAMINATION:  TEMP:          P.R:       B.P:       R.R 
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SYSTEMIC EXAMINATION: 
CVS 
RS 
PER ABDOMEN: 
CLINICAL DIAGNOSIS: 
DATE OF SURGERY 
 
Investigations: 
 
Preoperative and Postoperative investigation 
 
LFT  
T.bil  
D.bil  
SGOT  
SGPT  
GGT  
ALP  
 
CHEST X RAY : 
ABD X RAY: 
USG ABD: 
PATIENT CLINICAL COURSE: 
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OUTCOME OF TREATMENT: Study on the effect of carbondioxide 
used as pneumoperitoneum on liver functions in laproscopic         
cholecystectomy. 
Investigator: Dr.K.CHANDRASEKARAN,  PG  2nd year  –  MS    
(General Surgery). 
Guide: Prof. Dr. RUKMANGATHAN, PROF DR.K.RAJENDRAN, 
Chief, Unit S5.  
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PLAGIARISM 
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MASTER CHART 
sS. 
no 
Name Ip No Age Sex 
Mode of 
Surgery 
Pre Operative Lft Co2 
Pressure 
used 
Duration of 
Surgery 
Postop Lft 
Emer, elect T.b D.b Sgot Sgpt Alp T.b D.b Sgot Sgpt Alp 
1 Jaya 1025752 54 f emergency 1 0.6 54 36 158 12 1 1.2 0.5 50 37 190 
2 eisia 2838211 40 f emergency 1 0.2 38 20 30 12 2 1.1 0.1 40 40 60 
3 shanthi 2889355 46 f emergency 2 0.2 30 48 32 12 3 1.4 0.1 30 49 40 
4 mumtaz 2679267 29 f elective 2 0.1 40 28 59 13 2 1.7 0.2 50 50 40 
5 amutha 2752825 45 f elective 1 0.1 59 29 20 13 1 0.4 0.1 70 30 20 
6 kuppu 2710142 46 m elective 1 0.5 19 17 15 13 2 0.8 0.2 20 40 15 
7 raji 2073893 67 f emergency 1 0.1 40 20 14 14 3 0.7 0.2 50 10 10 
8 meenakshi 3097799 57 f emergency 1 0.3 41 26 23 14 2 1.5 0.2 20 50 46 
9 kamtchi 3056144 67 f elective 1 0.2 39 15 10 12 2 0.5 0.1 40 25 20 
10 revathy 3045321 33 f emergency 1 0.2 64 13 27 14 2 0.4 0.1 30 10 30 
11 aminammal 2792486 47 f elective 1 0.1 54 14 16 13 1 0.5 0.2 60 20 10 
12 indiragandi 1332288 45 f elective 2 0.6 79 24 31 12 1 0.5 0.1 80 40 20 
13 gayathri 2735197 60 f emergency 1 0.3 20 20 45 13 3 1.2 0.2 30 32 34 
14 krishnan 2589174 70 m emergency 2 0.6 79 24 31 14 3 1.5 0.8 80 60 40 
15 krisnamoorthy 3092255 52 m emergency 1 0.1 26 36 46 12 2 0.8 0.2 30 40 80 
16 praveena 3695721 33 f emergency 1 0.4 34 33 56 12 2 1.5 0.3 34 32 77 
17 tamilselvi 3149567 30 f elective 1 0.6 22 32 46 12 1 1 0.4 34 34 56 
18 sivagami 3715098 56 f elective 1 0.4 11 37 51 12 1 0.8 0.2 20 40 60 
19 Kala 3722758 65 f elective 1 0.4 11 37 51 12 1 1.2 0.6 15 40 43 
20 chandrammal 3993521 77 f elective 1 0.1 22 35 41 12 2 1.1 0.2 40 30 26 
21 shankar 3418450 65 m elective 2 0.6 23 22 34 13 2 1.5 0.2 25 24 45 
22 jayakar 3843925 49 m elective 1 0.4 14 39 58 13 2 0.9 0.1 20 35 59 
23 puspa 4208912 40 f elective 1 0.1 13 50 33 14 2 0.6 0.2 12 49 37 
24 parvathy 4197420 44 f elective 2 0.9 23 81 110 14 2 0.5 0.1 43 40 80 
25 mahalakshmi 4138386 26 f elective 1 0.6 38 46 40 14 2 1.5 0.1 30 26 40 
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 S. 
no Name Ip No Age Sex 
Mode of 
Surgery Pre Operative Lft 
Co2 
Pressure 
used 
Duration 
of 
Surgery 
Postop Lft 
Emer, elect T.b D.b Sgot Sgpt Alp T.b D.b Sgot Sgpt Alp 
26 Murugan 1027142 48 m elective 1.1 0.3 29 22 37 13 1 1.2 0.2 27 23 36 
27 Kalaivani 1102632 33 f emergency 2 0.4 22 26 33 12 2 1.8 0.3 20 25 34 
28 Jeya 1102154 34 f emergency 1 0.1 12 14 32 13 3 0.9 0.1 13 12 20 
29 mangalakhshmi 1151876 58 f emergency 0.8 0.2 11 11 20 14 3 0.7 0.2 15 15 22 
30 Dili 1052367 28 f emergency 0.9 0.3 20 20 32 12 2 0.9 0.2 20 18 35 
31 sakuntala 2105042 60 f emergency 1.5 0.2 24 22 35 13 1 1.6 0.1 22 27 32 
32 Savithri 1575523 35 f elective 0.6 0.2 32 30 61 13 2 0.5 0.1 33 31 60 
33 Kursith 1301313 39 m emergency 1.3 0.4 43 33 72 13 2 1.5 0.3 32 37 68 
34 Revathy 1305645 32 f elective 1.1 0.5 34 45 30 14 3 1 0.3 30 47 32 
35 Komala 1037976 35 f elective 0.9 0.2 30 34 50 12 3 0.8 0.4 30 37 52 
36 Amutha 1986543 45 f elective 0.8 0.1 20 19 72 13 2 0.9 0.2 15 15 84 
37 Sarada 1255328 40 f emergency 1.5 0.3 40 48 68 13 2 1.6 0.2 28 49 67 
38 shanthadevi 1114325 33 f emergency 1 0.5 28 35 50 14 2 1 0.4 30 40 50 
39 Mallika 1411432 50 f emergency 1.1 0.2 30 25 60 14 2 1.5 0.3 25 20 50 
40 Pramila 1146823 32 f emergency 1 0.5 28 35 50 14 1 1 0.4 30 30 80 
41 jagadeeswari 1610323 32 f emergency 1.5 0.6 20 38 55 14 1 1.5 0.4 20 19 44 
42 Chitra 1617740 35 f elective 1.3 0.4 30 36 65 14 1 1.4 0.3 30 30 64 
43 Manikam 1391200 30 m elective 1.1 0.3 24 26 46 14 3 1 0.2 20 22 49 
44 ganapathy 1528932 28 m elective 1.2 0.4 36 34 68 13 2 1 0.3 34 33 70 
45 Sankar 4048912 45 m elective 1.2 0.5 42 30 54 13 3 1.1 0.4 40 28 55 
46 saraswathy 3351822 35 f elective 1.2 0.5 23 24 24 14 1 1.2 0.6 30 30 80 
47 Sasikala 2624534 32 f emergency 1.3 0.6 54 36 150 14 1 1.4 0.5 50 50 100 
48 Srimathi 2618955 39 f emergency 3 1.3 36 46 380 13 4 1.5 0.5 40 50 200 
49 Elizabeth 2661430 50 f emergency 0.9 0.2 27 20 40 12 2 1 0.1 40 40 37 
50 Umarani 2680055 63 f emergency 0.6 0.3 24 32 74 12 1 0.5 0.1 30 30 76 
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